NDC 55529-014-05 - 300 PRO LA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55529-014
- Requested NDC
- 55529-014-05
- Package NDCs from labels
- 55529-014-02, 55529-014-04, 55529-014-05
- Manufacturer
- Norbrook Laboratories Limited
- Effective date
- 2023-09-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 300 PRO LA - Norbrook Laboratories Limited | Norbrook Laboratories Limited | 2023-09-27 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| oxytetracycline | ACTIVE INGREDIENT | X20I9EN955 | 300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED] | 2 | |
| oxytetracycline | ACTIVE MOIETY | X20I9EN955 | 300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED] | 2 | |
| glycerol formal | INACTIVE INGREDIENT | 3L7GR2604E | 300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED] | 2 | |
| magnesium oxide | INACTIVE INGREDIENT | 3A3U0GI71G | 300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED] | 2 | |
| polyethylene glycol | INACTIVE INGREDIENT | 3WJQ0SDW1A | 300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED] | 2 | |
| sodium formaldehyde sulfoxylate | INACTIVE INGREDIENT | X4ZGP7K714 | 300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitranol Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b81daf17-430b-6ba2-e053-2a95a90a768b | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexate | FOLIC ACID | PureTek Corporation | b34fee43-bea9-45b7-e053-2a95a90aad4d | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitrexate FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | b3637def-a701-673a-e053-2995a90a02d5 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Venexa | FOLIC ACID | PureTek Corporation | ba130779-cdfd-086d-e053-2a95a90a2590 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Venexa FE | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | ba142128-21c4-4204-e053-2a95a90ae0d7 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Ribotin-E | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfcd-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Ventrixyl Fe | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | c7a626ec-88ec-d899-e053-2a95a90ab0ba | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Zintrexyl-C | FERROUS FUMARATE, FOLIC ACID | PureTek Corporation | bb1492c5-bfca-d632-e053-2a95a90ad7d1 | 2023-01-11 | Warnings, Adverse reactions | 3A3U0GI71G |
| Magnesia Oxydata | MAGNESIA OXYDATA | Hahnemann Laboratories, INC. | e45bc2b0-72f4-42e1-e053-2995a90a0e66 | 2022-07-21 | 3A3U0GI71G | |
| Magnesium Oxide | MAGNESIUM OXIDE | Par Health | d5c123f8-1396-4d8c-96d3-e5ade96a6ef8 | 2020-11-10 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Par Health | d3c5b01b-f0d6-4503-ab18-b1a72386e2c6 | 2020-06-03 | Warnings | 3A3U0GI71G |
| Magnesium Oxide 400mg | MAGNESIUM OXIDE 400MG | Allegiant Health | 2ea68874-8c20-4284-bd0a-f07768057b83 | 2019-01-28 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Aphena Pharma Solutions - Tennessee, LLC | 11b2ce71-61fd-4e75-a859-a260b1dda080 | 2018-11-07 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Aphena Pharma Solutions - Tennessee, LLC | edabc9e4-60ad-407f-97c8-dfec5ee7eeb1 | 2018-10-25 | Warnings | 3A3U0GI71G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.